Expression of IL-21 and IL-33 in Intestinal Mucosa of Inflammatory Bowel Disease: An Immunohistochemical Study
Interleukins are considered to be potential therapeutic targets that can alter the prognosis and disease progression of IBD. IL-21 has proven to be involved in effector Th1, Th2 and Th17 responses. Similarly, IL-33, a newly identified cytokine, has been shown to control the Th1 effector response and...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2023-06-01
|
| Colecção: | Diagnostics |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2075-4418/13/13/2185 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|